Press Releases Cosmos Health Inc.

Stocks

COSM

US2214133058

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2026-07-14 pm EDT			5-day change	1st Jan Change
0.3071 ^USD	-0.42%		+19.63%	-38.33%

Jul. 02	Cosmos Health Expands Share Buyback to 3.4 Million Shares	MT
Jun. 30	Cosmos Health Inc. announces an Equity Buyback for $5 million worth of its shares.	CI

Press Releases

Jul. 14	Cosmos Health Share Buyback Expands to 4.49 Million Shares; Continues Open Market Repurchases	GL
Jul. 13	Cosmos Health Share Buyback Reaches 4.36 Million Shares; Continues Open Market Repurchases	GL
Jul. 13	Cosmos Health Accelerates Prescription Medicine Strategy with Libytec Partnership to Commercialize DIABIT-IS X in Greece	GL
Jul. 10	Cosmos Health Launches Subscription Model	GL
Jul. 09	Cosmos Health Expands Share Buyback to 4.14 Million Shares; Continues Open Market Repurchases	GL
Jul. 08	Cosmos Health Share Buyback Surpasses 4 Million Shares; Continues Open Market Repurchases	GL
Jul. 07	Cosmos Health Share Buyback Expands to 3.87 Million Shares; Continues Open Market Repurchases	GL
Jul. 07	Cosmos Health Reports Preliminary Record Q2 and H1 2026 Revenue, Up Over 30% Year-Over-Year; Continues Open Market Share Repurchases	GL
Jul. 06	Cosmos Health Share Buyback Increases to 3.64 Million Shares; Continues Open Market Purchases	GL
Jul. 02	Cosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market Purchases	GL
Jul. 01	Cosmos Health Completes Initial Repurchase of 2.65 Million Shares for $500,000; Continues Open Market Buybacks at Current Pace	GL
Jun. 30	Cosmos Health Authorizes Up to $5 Million Share Repurchase Program	GL
Jun. 26	Cosmos Health Signs Distribution Agreement With IMC, Owner of Qatar's Largest Pharmacy Chain; Secures Initial Purchase Order of 31,000 Sky Premium Life Units	GL
Jun. 25	Cosmos Health Advances International Patent Application for Its Proprietary Hydrogel Weight Management Platform Across the U.S., Europe, Australia, and Canada	GL
Jun. 24	Cosmos Health : C-Sept PRO Gains Strong Traction Across Leading Greek Public and Private Hospital Groups, With Annualized Sales Poised to Exceed $1.3 Million at Approximately 72% Gross Margin	PU
Jun. 24	Cosmos Health’s C-Sept PRO Gains Strong Traction Across Leading Greek Public and Private Hospital Groups, With Annualized Sales Poised to Exceed $1.3 Million at Approximately 72% Gross Margin	GL
Jun. 23	Cosmos Health Signs Agreement to Deploy Artificial Intelligence (AI)-Powered Call Center to Optimize Order Intake, Customer Communications, and Operating Efficiency	GL
Jun. 22	Cosmos Health Builds Contract Manufacturing Orderbook to Over 25 Million Units; Division Positioned to Generate Over $10 Million in Recurring Annual Profit	GL
Jun. 18	CosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility Capacity	GL
Jun. 17	Cosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United States	GL
Jun. 17	Cosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological Products	GL
Jun. 15	Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit	GL
Jun. 15	Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit	AQ
Jun. 12	Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines	GL
Jun. 12	Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross Profit	GL